JPS5416510B2 - - Google Patents

Info

Publication number
JPS5416510B2
JPS5416510B2 JP2364173A JP2364173A JPS5416510B2 JP S5416510 B2 JPS5416510 B2 JP S5416510B2 JP 2364173 A JP2364173 A JP 2364173A JP 2364173 A JP2364173 A JP 2364173A JP S5416510 B2 JPS5416510 B2 JP S5416510B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP2364173A
Other languages
Japanese (ja)
Other versions
JPS4899185A (en:Method
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4899185A publication Critical patent/JPS4899185A/ja
Publication of JPS5416510B2 publication Critical patent/JPS5416510B2/ja
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
JP2364173A 1972-03-01 1973-02-27 Expired JPS5416510B2 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7206981A FR2173746B1 (en:Method) 1972-03-01 1972-03-01

Publications (2)

Publication Number Publication Date
JPS4899185A JPS4899185A (en:Method) 1973-12-15
JPS5416510B2 true JPS5416510B2 (en:Method) 1979-06-22

Family

ID=9094373

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2364173A Expired JPS5416510B2 (en:Method) 1972-03-01 1973-02-27

Country Status (14)

Country Link
US (1) US3843656A (en:Method)
JP (1) JPS5416510B2 (en:Method)
AR (1) AR195597A1 (en:Method)
BE (1) BE796114A (en:Method)
CA (1) CA977756A (en:Method)
CH (1) CH556858A (en:Method)
DE (1) DE2307536C3 (en:Method)
DK (1) DK130978B (en:Method)
ES (1) ES412182A1 (en:Method)
FR (1) FR2173746B1 (en:Method)
GB (1) GB1363047A (en:Method)
NL (1) NL179026C (en:Method)
NO (1) NO137236C (en:Method)
SE (1) SE398750B (en:Method)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2281117A2 (fr) * 1974-08-09 1976-03-05 Ugine Kuhlmann Nouvelles piperazino-pyrimidines utilisables comme medicaments
US4166852A (en) * 1974-08-09 1979-09-04 Produits Chimiques Ugine Kuhlmann Piperazino-pyrimidines and their use as spasmolytic agents
CH602663A5 (en:Method) * 1975-05-23 1978-07-31 Mar Pha Etu Expl Marques
FR2417507A2 (fr) * 1977-07-28 1979-09-14 Ugine Kuhlmann Diamino-2,4 (ou -4,6) methylthio-5 pyrimidines herbicides
FR2503162A1 (fr) * 1981-04-07 1982-10-08 Pharmindustrie Nouveaux derives de piperazino-2 pyrimidine, procedes pour leur preparation et leur utilisation comme medicaments ou comme intermediaires pour la fabrication de medicaments
DE3417264A1 (de) * 1984-05-10 1985-11-14 Bayer Ag, 5090 Leverkusen Neue 2,4-diamino-6-halogen-5-alkylthio-pyrimidine
EP0826674A4 (en) * 1995-04-03 1998-07-08 Sumitomo Pharma EFFECTIVE PYRIMIDINE DERIVATIVES AS PSYCHOTROPE, AND METHOD FOR THE PRODUCTION THEREOF

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB951431A (en) * 1959-03-17 1964-03-04 Wellcome Found Pyrimidine derivatives and the manufacture thereof

Also Published As

Publication number Publication date
NL179026C (nl) 1986-07-01
NO137236C (no) 1978-01-25
NO137236B (no) 1977-10-17
JPS4899185A (en:Method) 1973-12-15
ES412182A1 (es) 1976-01-01
AR195597A1 (es) 1973-10-23
DK130978B (da) 1975-05-12
FR2173746B1 (en:Method) 1975-04-25
US3843656A (en) 1974-10-22
BE796114A (fr) 1973-08-28
DE2307536A1 (de) 1973-09-13
SE398750B (sv) 1978-01-16
NL179026B (nl) 1986-02-03
DK130978C (en:Method) 1975-10-13
DE2307536B2 (de) 1979-06-28
GB1363047A (en) 1974-08-14
DE2307536C3 (de) 1980-03-06
CH556858A (fr) 1974-12-13
CA977756A (en) 1975-11-11
NL7301936A (en:Method) 1973-09-04
FR2173746A1 (en:Method) 1973-10-12

Similar Documents

Publication Publication Date Title
JPS4919882U (en:Method)
CH575934A5 (en:Method)
CH592052A5 (en:Method)
BG18501A1 (en:Method)
BG18698A1 (en:Method)
BG18919A1 (en:Method)
BG22072A3 (en:Method)
CH1052173A4 (en:Method)
CH1762972A4 (en:Method)
CH188673A4 (en:Method)
CH559284A5 (en:Method)
CH559377A5 (en:Method)
CH559416A5 (en:Method)
CH574165A5 (en:Method)
CH559643A5 (en:Method)
CH559842A5 (en:Method)
CH561140A5 (en:Method)
CH561402A5 (en:Method)
CH562678A5 (en:Method)
CH563631A5 (en:Method)
CH563646A5 (en:Method)
CH563654A5 (en:Method)
CH563783A5 (en:Method)
CH564401A5 (en:Method)
CH564993A5 (en:Method)